Please assess the completion status of the following clinical trial:

Trial Title: Ibuprofen Use on Post-operative Pain Following Cholecystectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA grade I-II patients~* Aged 18-65 years~Exclusion Criteria:~* History of allergies or hypersensitivity to the aforementioned agents~* Renal, hepatic or gastrointestinal disease~* Significant cognitive impairment~* Recent use of long-term nonsteroid anti-inflammatory and opioids~* Oral anticoagulant use or known bleeding disorders~* Diabetes or any other neuropathic diseases~* Pregnancy or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Acetaminophen group (Type: ACTIVE_COMPARATOR): The acetaminophen group (n=35) received 1000 of mg acetaminophen intravenously in 100 mL saline at the end of the cholecystectomy.
- Ibuprofen group (Type: EXPERIMENTAL): The ibuprofen group (n=36) was administered 800 mg of ibuprofen at the end of the cholecystectomy.

Based on this trial design, predict the completion outcome and termination type (if applicable).